Substrate Utilization and Cycling Performance Following Palatinose™ Ingestion: A Randomized, Double-Blind, Controlled Trial

(1) Objective: To compare the effects of isomaltulose (Palatinose™, PSE) vs. maltodextrin (MDX) ingestion on substrate utilization during endurance exercise and subsequent time trial performance; (2) Methods: 20 male athletes performed two experimental trials with ingestion of either 75 g PSE or MDX...

Full description

Bibliographic Details
Main Authors: Daniel König, Denise Zdzieblik, Anja Holz, Stephan Theis, Albert Gollhofer
Format: Article
Language:English
Published: MDPI AG 2016-06-01
Series:Nutrients
Subjects:
Online Access:http://www.mdpi.com/2072-6643/8/7/390
id doaj-df6bbf425743410ba7862701c609d069
record_format Article
spelling doaj-df6bbf425743410ba7862701c609d0692020-11-25T02:01:41ZengMDPI AGNutrients2072-66432016-06-018739010.3390/nu8070390nu8070390Substrate Utilization and Cycling Performance Following Palatinose™ Ingestion: A Randomized, Double-Blind, Controlled TrialDaniel König0Denise Zdzieblik1Anja Holz2Stephan Theis3Albert Gollhofer4Section for Nutrition and Sports, Department of Sports and Sports Science, University of Freiburg, Schwarzwaldstrasse 175, Freiburg 79117, GermanySection for Nutrition and Sports, Department of Sports and Sports Science, University of Freiburg, Schwarzwaldstrasse 175, Freiburg 79117, GermanyBENEO-Institute, Wormserstrasse 11, Obrigheim 67283, GermanyBENEO-Institute, Wormserstrasse 11, Obrigheim 67283, GermanySection for Nutrition and Sports, Department of Sports and Sports Science, University of Freiburg, Schwarzwaldstrasse 175, Freiburg 79117, Germany(1) Objective: To compare the effects of isomaltulose (Palatinose™, PSE) vs. maltodextrin (MDX) ingestion on substrate utilization during endurance exercise and subsequent time trial performance; (2) Methods: 20 male athletes performed two experimental trials with ingestion of either 75 g PSE or MDX 45 min before the start of exercise. The exercise protocol consisted of 90 min cycling (60% VO2max) followed by a time trial; (3) Results: Time trial finishing time (−2.7%, 90% CI: ±3.0%, 89% likely beneficial; p = 0.147) and power output during the final 5 min (+4.6%, 90% CI: ±4.0%, 93% likely beneficial; p = 0.053) were improved with PSE compared with MDX. The blood glucose profile differed between trials (p = 0.013) with PSE resulting in lower glycemia during rest (95%–99% likelihood) and higher blood glucose concentrations during exercise (63%–86% likelihood). In comparison to MDX, fat oxidation was higher (88%–99% likelihood; p = 0.005) and carbohydrate oxidation was lower following PSE intake (85%–96% likelihood; p = 0.002). (4) Conclusion: PSE maintained a more stable blood glucose profile and higher fat oxidation during exercise which resulted in improved cycling performance compared with MDX. These results could be explained by the slower availability and the low-glycemic properties of Palatinose™ allowing a greater reliance on fat oxidation and sparing of glycogen during the initial endurance exercise.http://www.mdpi.com/2072-6643/8/7/390isomaltuloseathletic performancefat oxidationglycemic indexendurance
collection DOAJ
language English
format Article
sources DOAJ
author Daniel König
Denise Zdzieblik
Anja Holz
Stephan Theis
Albert Gollhofer
spellingShingle Daniel König
Denise Zdzieblik
Anja Holz
Stephan Theis
Albert Gollhofer
Substrate Utilization and Cycling Performance Following Palatinose™ Ingestion: A Randomized, Double-Blind, Controlled Trial
Nutrients
isomaltulose
athletic performance
fat oxidation
glycemic index
endurance
author_facet Daniel König
Denise Zdzieblik
Anja Holz
Stephan Theis
Albert Gollhofer
author_sort Daniel König
title Substrate Utilization and Cycling Performance Following Palatinose™ Ingestion: A Randomized, Double-Blind, Controlled Trial
title_short Substrate Utilization and Cycling Performance Following Palatinose™ Ingestion: A Randomized, Double-Blind, Controlled Trial
title_full Substrate Utilization and Cycling Performance Following Palatinose™ Ingestion: A Randomized, Double-Blind, Controlled Trial
title_fullStr Substrate Utilization and Cycling Performance Following Palatinose™ Ingestion: A Randomized, Double-Blind, Controlled Trial
title_full_unstemmed Substrate Utilization and Cycling Performance Following Palatinose™ Ingestion: A Randomized, Double-Blind, Controlled Trial
title_sort substrate utilization and cycling performance following palatinose™ ingestion: a randomized, double-blind, controlled trial
publisher MDPI AG
series Nutrients
issn 2072-6643
publishDate 2016-06-01
description (1) Objective: To compare the effects of isomaltulose (Palatinose™, PSE) vs. maltodextrin (MDX) ingestion on substrate utilization during endurance exercise and subsequent time trial performance; (2) Methods: 20 male athletes performed two experimental trials with ingestion of either 75 g PSE or MDX 45 min before the start of exercise. The exercise protocol consisted of 90 min cycling (60% VO2max) followed by a time trial; (3) Results: Time trial finishing time (−2.7%, 90% CI: ±3.0%, 89% likely beneficial; p = 0.147) and power output during the final 5 min (+4.6%, 90% CI: ±4.0%, 93% likely beneficial; p = 0.053) were improved with PSE compared with MDX. The blood glucose profile differed between trials (p = 0.013) with PSE resulting in lower glycemia during rest (95%–99% likelihood) and higher blood glucose concentrations during exercise (63%–86% likelihood). In comparison to MDX, fat oxidation was higher (88%–99% likelihood; p = 0.005) and carbohydrate oxidation was lower following PSE intake (85%–96% likelihood; p = 0.002). (4) Conclusion: PSE maintained a more stable blood glucose profile and higher fat oxidation during exercise which resulted in improved cycling performance compared with MDX. These results could be explained by the slower availability and the low-glycemic properties of Palatinose™ allowing a greater reliance on fat oxidation and sparing of glycogen during the initial endurance exercise.
topic isomaltulose
athletic performance
fat oxidation
glycemic index
endurance
url http://www.mdpi.com/2072-6643/8/7/390
work_keys_str_mv AT danielkonig substrateutilizationandcyclingperformancefollowingpalatinoseingestionarandomizeddoubleblindcontrolledtrial
AT denisezdzieblik substrateutilizationandcyclingperformancefollowingpalatinoseingestionarandomizeddoubleblindcontrolledtrial
AT anjaholz substrateutilizationandcyclingperformancefollowingpalatinoseingestionarandomizeddoubleblindcontrolledtrial
AT stephantheis substrateutilizationandcyclingperformancefollowingpalatinoseingestionarandomizeddoubleblindcontrolledtrial
AT albertgollhofer substrateutilizationandcyclingperformancefollowingpalatinoseingestionarandomizeddoubleblindcontrolledtrial
_version_ 1724956430413332480